Aims: To determine differences in life backgrounds and clinical features between methamphetamine (MAP) smokers and injectors in Japan.
Setting: Out-patient clinic at a psychiatric centre.
Participants: Among 451 MAP abusers undergoing initial assessments, 116 subjects whom the first author had directly interviewed and treated were studied.